reference/27001496

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27001496

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	1049
issn	0959-4973
issueIdentifier	10
pageRange	1044-1049
publicationName	Anti-Cancer Drugs
startingPage	1044
bibliographicCitation	Romiti A, Roberto M, D'Antonio C, Onesti CE, Barucca V, Milano A, Gentile G, Lionetto L, Medda E, Mazzuca F, Botticelli A, Falcone R, Simmaco M, Marchetti P. The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anticancer Drugs. 2016 Nov;27(10):1044–9. doi: 10.1097/cad.0000000000000429. PMID: 27557140.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32f6cc1c7bcdd4790957220d332c6291 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b956f9989d60da340428705d58ab014 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_406f9f444665e40cf77eb78859978b78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9679-4711 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79e16218462830742393e31b70ca5acc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ff2abcb870b5e78ef369d57ea434dc1b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ffbc91ed85d35848fb97bc5552b4a789 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be9083320fe9beaa38c54b43cc1246d8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5c4b6bd70efed466831f15dd9d94f338 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fade04b32f13219df9ccd6ca187c4ec6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d29fe090a37f71180372ac4531d43d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b56095f10758ce80ae798a45fcadbfd6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_918d7bfbfa8eade41b3ecacb197460de http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e4f48dd0c10d0786add75abf02c06842 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ee61a441d13c21ba66e7079101e7bec
date	201611
identifier	https://pubmed.ncbi.nlm.nih.gov/27557140 https://doi.org/10.1097/cad.0000000000000429
isPartOf	https://portal.issn.org/resource/ISSN/0959-4973 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1267
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer
discusses	http://id.nlm.nih.gov/mesh/M000608867 http://id.nlm.nih.gov/mesh/M0021454 http://id.nlm.nih.gov/mesh/M0137645 http://id.nlm.nih.gov/mesh/M0575211 http://id.nlm.nih.gov/mesh/M0287377
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D005770Q000188 http://id.nlm.nih.gov/mesh/D000069287Q000008 http://id.nlm.nih.gov/mesh/D005770Q000235 http://id.nlm.nih.gov/mesh/D013940Q000235 http://id.nlm.nih.gov/mesh/D004742
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D011401 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D020641 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D042965Q000235
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_897da9d19e43f4cebb1d75cfd8b37c7b http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141643 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ee41b89e209f306b4571ed288c447cc6 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7811 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7812 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f711b441c08d32e3c24e3fd3df4a2c3d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID7298

Total number of triples: 60.